trial · primary record
Enlicitide Decanoate
Hyperlipidemia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2027-11-26 |
| Primary endpoint | Mean Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) at Week 24 |
| Registry ID | NCT07821944 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:03.967Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07821944
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Enlicitide Decanoate · approval
- Enlicitide Decanoate · compound